295 results on '"Elia, Giuliano"'
Search Results
2. Intralesional administration of L19IL2/L19TNF in high-risk locally advanced basal cell carcinoma or cutaneous squamous cell carcinoma.
3. Intralesional administration of L19IL2/L19TNF in difficult-to-treat BCC patients shows favorable safety profile and leads to complete remission of tumor lesions
4. A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients
5. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
6. Lessons from April 6, 2009 L’Aquila earthquake to enhance microzoning studies in near-field urban areas
7. Cell Surface Protein Biotinylation for SDS-PAGE Analysis
8. Supplementary Table 1 from Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
9. Data from Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
10. Data from Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
11. Supplementary Methods from Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
12. Supplementary Figure 1 from Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
13. Supplementary Table 1 from Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
14. Supplementary Table 2 from Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
15. Supplementary Figure 2 from Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
16. Inhibition of Nuclear Factor κ B by Prostaglandin A1: An Effect Associated with Heat Shock Transcription Factor Activation
17. Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature
18. Blood biocompatibility of surface-bound multi-walled carbon nanotubes
19. Intralesional treatment of metastatic melanoma: a review of therapeutic options
20. From target discovery to clinical trials with armed antibody products
21. DIGE Analysis of Animal Tissues
22. Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
23. Armed antibodies for cancer treatment: a promising tool in a changing era
24. Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets
25. Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts
26. Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
27. Human plasma protein adsorption onto alumina nanoparticles relevant to orthopedic wear
28. Citrullination of Proteins as a Specific Response Mechanism in Plants
29. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
30. Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial
31. Cell Surface Protein Biotinylation for SDS-PAGE Analysis
32. Two-dimensional mass spectrometric mapping
33. Quantitative Recovery of Biotinylated Proteins from Streptavidin-Based Affinity Chromatography Resins
34. Proteomic profiling of the human T-cell nucleolus
35. Citrullination of proteins as a specific response mechanism in plants
36. Limited efficacy of intratumoral IL-2 applied to large melanoma metastases
37. Differentiating germinal center-derived lymphomas through their cellular microenvironment
38. The Germinal centre-derived lymphomas seen through their cellular microenvironment
39. Inhibition of nuclear factor kappaB by prostaglandin A1: an effect associated with heat shock transcription factor activation
40. Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
41. Affinity-capture reagents for protein arrays
42. Stress Proteins in Inflammationa
43. Comparative Proteomic Profiling of Divergent Phenotypes for Water Holding Capacity across the Post Mortem Ageing Period in Porcine Muscle Exudate
44. Wheat germ agglutinin-binding protein changes in highly malignant Friend leukemia cells metastasizing to the liver
45. The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer
46. Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer
47. Transcriptomic and proteomic approaches to the discovery of new markers of pathology
48. Quantitative Recovery of Biotinylated Proteins from Streptavidin-Based Affinity Chromatography Resins
49. Armed antibodies for cancer treatment: a promising tool in a changing era
50. Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.